Skip to Main content Skip to Navigation
Journal articles

A subset of epithelioid and spindle cell rhabdomyosarcomas is associated with TFCP2 fusions and common ALK upregulation

Francois Le Loarer 1, 2, 3 Arjen Cleven 4 Corinne Bouvier 5 Marie-Pierre Castex 6 Cleofe Romagosa 7 Anne Moreau 8 Sebastien Salas 9 Benjamin Bonhomme 1 Anne Gomez-Brouchet 10 Camille Laurent 10 Sophie Le Guellec 10 Virginie Audard 11 Antoine Giraud 12 Irma Ramos-Oliver 7 Anne-Marie Cleton-Jansen 4 Dilara Savci-Heijink 13 Herman Kroon 4 Jessica Baud 2, 3 Daniel Pissaloux 14, 15 Gaëlle Pierron 16 Anand Sherwood 17 Jean Michel Coindre 1, 2, 3 Judith Bovée 4 Frédérique Larousserie 11 Franck Tirode 15
Abstract : Rhabdomyosarcomas with TFCP2 fusions represent an emerging subtype of tumors, initially discovered by RNA-sequencing. We report herein the clinicopathological, transcriptional, and genomic features of a series of 14 cases. Cases were retrospectively and prospectively recruited and studied by immunohistochemistry (MYF4, MYOD1, S100, AE1/E3, ALK), fluorescence in situ hybridization with TFCP2 break-apart probe (n = 10/14), array-comparative genomic hybridization (Agilent), whole RNA-sequencing (Truseq Exome, Illumina), or anchored multiplex PCR-based targeted next-generation sequencing (Archer® FusionPlex® Sarcoma kit). Patient's age ranged between 11 and 86 years, including 5 pediatric cases. Tumors were located in the bone (n = 12/14) and soft tissue (n = 2/14). Most bone tumors invaded surrounding soft tissue. Craniofacial bones were over-represented (n = 8/12). Median survival was 8 months and five patients are currently alive with a median follow-up of 20 months. Most tumors displayed a mixed spindle cell and epithelioid pattern with frequent vesicular nuclei. All tumors expressed keratins and showed a rhabdomyogenic phenotype (defined as expression of MYF4 and/or MYOD1). ALK was overexpressed in all but three cases without underlying ALK fusion on break-apart FISH (n = 5) nor next-generation sequencing (n = 14). ALK upregulation was frequently associated with an internal deletion at genomic level. TFCP2 was fused in 5' either to EWSR1 (n = 6) or FUS (n = 8). EWSR1 was involved in both soft tissue cases. FISH with TFCP2 break-apart probe was positive in all tested cases (n = 8), including one case with unbalanced signal. On array-CGH, all tested tumors displayed complex genetic profiles with genomic indexes ranging from 13 to 107.55 and recurrent CDKN2A deletions. FET-TFCP2 rhabdomyosarcomas clustered together and distinctly from other rhabdomyosarcomas subgroups. Altogether, our data confirm and expand the spectrum of the new family of FET-TFCP2 rhabdomyosarcomas, which are associated with a predilection for the craniofacial bones, an aggressive course, and recurrent pathological features. Their association with ALK overexpression might represent a therapeutic vulnerability.
Complete list of metadata

Cited literature [38 references]  Display  Hide  Download

https://www.hal.inserm.fr/inserm-02440660
Contributor : Franck Tirode <>
Submitted on : Wednesday, January 15, 2020 - 12:01:14 PM
Last modification on : Friday, April 9, 2021 - 8:38:01 AM
Long-term archiving on: : Thursday, April 16, 2020 - 2:49:19 PM

File

draft to submit.pdf
Files produced by the author(s)

Identifiers

Collections

Citation

Francois Le Loarer, Arjen Cleven, Corinne Bouvier, Marie-Pierre Castex, Cleofe Romagosa, et al.. A subset of epithelioid and spindle cell rhabdomyosarcomas is associated with TFCP2 fusions and common ALK upregulation. Modern Pathology, Nature Publishing Group: Open Access Hybrid Model Option B, 2019, ⟨10.1038/s41379-019-0323-8⟩. ⟨inserm-02440660⟩

Share

Metrics

Record views

321

Files downloads

590